These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3509363)

  • 41. [In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Jul; 24(3):248-50. PubMed ID: 2283976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H; Sahin A; Chryssouli Z
    Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro comparison of ciprofloxacin to parenteral antibiotics.
    Speciale A; Caccamo F; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):154-6. PubMed ID: 16312349
    [No Abstract]   [Full Text] [Related]  

  • 44. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro activity of several antibiotics on pathogenic micro-organisms isolated from the lower respiratory tract].
    Allocco A; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1994; 86(1-12):15-28. PubMed ID: 8706972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The sensitivity to aztreonam and 10 other antibiotics of multiresistant enterobacteria.
    Koumentakou I; Kouskouni E; Kourkouli R; Papachristou E; Philippopoulou E; Kassimatis V; Papoulias G
    J Chemother; 1989 Jul; 1(4 Suppl):362-3. PubMed ID: 16312440
    [No Abstract]   [Full Text] [Related]  

  • 48. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Carumonam: antibacterial activity in vitro].
    Garlaschi ML; Lombardi A; Castiglioni G; Abbiati R; Varotto F
    G Ital Chemioter; 1991; 38(1-3):185-7. PubMed ID: 1365586
    [No Abstract]   [Full Text] [Related]  

  • 51. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic susceptibility of bacteria isolated from cats with ulcerative keratitis in Taiwan.
    Lin CT; Petersen-Jones SM
    J Small Anim Pract; 2008 Feb; 49(2):80-3. PubMed ID: 17850276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper amendment of agricultural soil selects for bacterial antibiotic resistance in the field.
    Berg J; Tom-Petersen A; Nybroe O
    Lett Appl Microbiol; 2005; 40(2):146-51. PubMed ID: 15644115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of aztreonam susceptibility results obtained with the MicroScan system to reference tests.
    Zimmer BL; Brattebo J; Bryant M; Capo A; Chipman A; Miller R; Wehr C; Van Pelt L
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):111-20. PubMed ID: 9368088
    [No Abstract]   [Full Text] [Related]  

  • 55. [Gram-negative bacteria in suppurative wounds].
    Ukhov AIa; Petrus VS; Shvaĭdetskaia GV
    Mikrobiol Zh (1978); 1988; 50(6):36-40. PubMed ID: 3249592
    [No Abstract]   [Full Text] [Related]  

  • 56. [In vitro activities of aztreonam and sulbactam/ampicillin for gram-negative bacteria].
    Ozkuyumcu C; Durupinar B; Dikmen N
    Mikrobiyol Bul; 1989 Jan; 23(1):77-9. PubMed ID: 2626099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 58. Serious interpretive error among three commercial systems for susceptibility testing of aztreonam. Aztreonam Study Group.
    Marshall SA
    Diagn Microbiol Infect Dis; 1995 Jul; 22(3):249-51. PubMed ID: 8565412
    [No Abstract]   [Full Text] [Related]  

  • 59. Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):57-60. PubMed ID: 7789099
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibacterial mechanisms of synthetic monobactams against gram-negative bacilli].
    Mitsui K
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):373-90. PubMed ID: 3504872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.